ESC 365 - Efficacy of rivaroxaban compared to standard of care in preventing ischemic stroke in adults with coronary or peripheral vascular disease: an integrated analysis using patient-level data

ESC Premium Access

Efficacy of rivaroxaban compared to standard of care in preventing ischemic stroke in adults with coronary or peripheral vascular disease: an integrated analysis using patient-level data

Session: Stroke and Atherosclerosis – From Risk Evaluation to Treatment

Topic: Prevention

Speaker: Doctor E. Barnathan (Spring House, US)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Elliot Barnathan

Janssen R and D LLC, Spring House (United States of America)

0 follower

2 more presentations in this session

Differential impact of life-long lower LDL-C levels on ischaemic stroke subtypes and coronary heart disease risk among 1 million individuals

Speaker: Associate Professor J. Hopewell (Oxford, GB)

Cardiac troponin I and incident stroke in European cohorts - insights from the BiomarCaRE project

Speaker: Doctor S. Camen (Hamburg, DE)

Access the full session

Stroke and Atherosclerosis – From Risk Evaluation to Treatment

Speakers: Doctor E. Barnathan, Associate Professor J. Hopewell, Doctor S. Camen

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources